PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report - Top-Institutions - MDSpire

PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report

  • By

  • Yanke Li

  • Yu Xia

  • Lei Wang

  • Xiaomei Liu

  • Zhenhua Du

  • May 28, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Shengjing Hospital of China Medical University
    Shengjing Hospital of China Medical University

    Shenyang, Liaoning

    Key Differentiators

    • Oncology

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #3

    University of Milan-Bicocca
    University of Milan-Bicocca

    Milan, Lombardy

    Key Differentiators

    • Oncology

  • #4

    European Institute of Oncology
    European Institute of Oncology

    Milan, Lombardy

    Key Differentiators

    • Oncology

  • #5

    University of Arizona Cancer Center
    University of Arizona Cancer Center

    Tucson, Arizona

    Key Differentiators

    • Oncology

Original Source(s)

PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report

  • by Yanke Li, Yu Xia, Lei Wang, Xiaomei Liu, Zhenhua Du

  • May 28, 2026

Related Content

Combination therapy with anti-PD-1 antibody, radiotherapy, and tyrosine kinase inhibitor for unresectable primary ectopic hepatocellular carcinoma: a case report with genomic profiling and literature review

Colorectal Cancer Treatment Delay Thresholds and Metastasis Risk

Underutilisation of rehabilitation for children with cancer in Gaza: the experience of the non-governmental organisation Children Not Numbers